You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in the Philippines

Jun 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Philippines with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Philippines, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Philippines for free:

The Consumer Health in Philippines market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Philippines?
  • What are the major brands in Philippines?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health reports slower growth in 2010

Amid the more vibrant economic backdrop, consumer health reported slower growth in 2010 compared to 2009. In contrast to the previous year where consumers invested in vitamins and dietary supplements to boost their immune systems, the sale of preventive healthcare products witnessed somewhat of a downturn. Furthermore, consumption of over-the-counter medicines remained sluggish.

Manufacturers invest in aggressive promotional strategies to boost sales

2010 witnessed manufacturers pushing their brands through the use of aggressive promotional strategies geared towards the emerging lifestyle of consumers. Overall leader United Laboratories Inc was at the forefront of harnessing the rise in health consciousness through its Run for Wellness. Brands such as Ascof Lagundi, Cherifer, Licealiz, and Fern-C all continued to sponsor sporting activities to stress their support of maintaining a healthier lifestyle. Social networking sites, more predominantly Facebook, were also utilised in order to reach a niche of middle-income and high-end consumers.

United Laboratories Inc retains overall leadership

United Laboratories Inc solidified its strength in consumer health in 2010 through its three-pronged strategy of competitive pricing, advertising campaigns to ensure strong brand recall, and continuous innovation. The company took a step ahead in widening its portfolio to include brands which keep abreast of emerging consumer lifestyles. Throughout the year, the company sustained its leading position in analgesics, cough, colds and allergy (hay fever) remedies, and vitamins and dietary supplements.

Parapharmacies/drugstores accounts for bulk of consumer health sales

The mushrooming of The Generics Pharmacy and Generica through franchising as well as the conversion of chemists/pharmacists brands such as Mercury and Rose Pharmacy into parapharmacies/drugstores strengthened the position of these channels in the distribution of consumer health, leading to these channels holding the majority value share of sales in 2010.

Consumer health to display healthy growth rates over forecast period

With Filipino consumers placing higher importance on their health, consumer health is projected to expand further over forecast period. Over-the-counter medication is seen to be driven by population growth while spending on vitamins and dietary supplements will be stimulated by innovations in overall consumer health as well as the positioning that manufacturers adopt. The marriage of beauty and wellness will continue to be a prevalent theme in the medium-term, while preventive medicine will be supported by the more stressful lifestyles in the metropolis.

Table of Contents

Table of Contents

Consumer Health in the Philippines - Industry Overview

EXECUTIVE SUMMARY

Consumer health reports slower growth in 2010

Manufacturers invest in aggressive promotional strategies to boost sales

United Laboratories Inc retains overall leadership

Parapharmacies/drugstores accounts for bulk of consumer health sales

Consumer health to display healthy growth rates over forecast period

KEY TRENDS AND DEVELOPMENTS

Better economic performance in the Philippines during 2010 fails to induce greater spending for consumer health

Consumer health increasingly competes with beauty and personal care

Manufacturers utilise social networking sites in product promotion

Government keeps a closer eye on consumer health

Local companies remain strong amid changes in competitive landscape

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in the Philippines - Company Profiles

Dermpharma Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Dermpharma Inc: Competitive Position 2010

International Pharmaceuticals Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 International Pharmaceuticals Inc: Competitive Position 2010

Pascual Laboratories Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Pascual Laboratories Inc: Competitive Position 2010

United Laboratories Inc in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 United Laboratories Inc: Competitive Position 2010

Universal Robina Corp in Consumer Health (Philippines)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Universal Robina Corp: Competitive Position 2010

Adult Mouth Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The continued aggressive advertising campaigns of beauty and personal care products such as toothpaste and mouthwash continued to create a blur between cosmetics and consumer health brands. The prevalence of more innovations focused on delivering complete oral care protection and more efficient germ killing mouthwashes continued to overshadow adult mouth care. Thus, customers did not feel the strong need to purchase medicated adult mouth care, relying instead on more affordable and popular oral care brands which prevent mouth disease.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Philippines) Inc remains the largest player in adult mouth care garnering retail value share of 49% translating into Ps89.6 million total sales. The company’s brand Bactidol enjoys strong brand equity in the category and is synonymous with efficiency. The product has a loyal pool of customers who are willing to pay a higher price for the perceived better performance of the brand.

PROSPECTS

  • Adult mouth care will continue to experience negative real growth during the forecast period especially as oral care products such as toothpaste and mouthwash will continue to highlight their innovations featuring ingredients to counter bad breath, gum disease, mouth ulcers, and bacteria. With the expected inactivity among adult mouth care manufacturers in 2010, there will be further delineation between cosmetic and OTC products.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The faster paced lifestyles in the Philippines pushed manufacturers to focus on delivering the fastest possible relief from pain. During 2010, Alaxan continued to emphasise its “fast release” with the product’s advertisement with international boxing champion Manny Pacquiao stressing that pain should not get in the way of attaining success. On the other hand, newly launched Biogesic for Kids also stressed how it can offer rapid relief from fever by working in as fast as 15 minutes. Lastly, United Laboratories Inc launched a new variant of its ibuprofen brand Medicol. The new product Medicol Advance boasts of being the fastest acting product in its segment due to its combination of soluble ibuprofen and soft gel capsule.

SWITCHES

COMPETITIVE LANDSCAPE

  • United Laboratories Inc remained the undisputed leader in analgesics capturing 55% share of total retail sales. The company has long capitalised on its portfolio of popular brands established by its consistently aggressive advertising strategy. Its brands Alaxan, Biogesic, and Medicol are all leaders in their respective segments. United Laboratories Inc is lauded for its ability to segment its market and its competence in establishing brand image to differentiate the products in its portfolio. For instance, Medicol is mostly targeted for headaches, Alaxan for body aches and Dolfenal for toothache.

PROSPECTS

  • The consumption of analgesics in the Philippines will continue to remain incident driven; that is, customers are not expected to stock up on analgesics and will simply purchase a product when plagued by body pains. Thus, over the forecast period it is projected that companies will continue to serve consumers using blisters and strip packs which will make products more affordable. Products will also be made more accessible through the mushrooming of more parapharmacies/drugstores.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The continued expansion of the business process outsourcing in the Philippines assured a steady market for calming and sleeping. Employing Filipinos who are usually required during the night to cope with Western clients’ time zones, business process outsourcing workers often resort to calming and sleeping products to aid them in getting enough sleep during the day. During 2010, these employees remained as the largest consumer group of calming and sleeping in the Philippines.

SWITCHES

COMPETITIVE LANDSCAPE

  • Organica Neutraceuticals Inc, the manufacturer of the Sleepasil brand remained the most dominant player in calming and sleeping in the Philippines. Capitalising on its identity as one of the earliest players in the category, the company held 48% value share in 2010. Another successful factor for the company is that Sleepasil is a herbal-based product which attracts customers due to the perception that it is safe, gentle, and does not have adverse side effects.

PROSPECTS

  • Amid the deeper penetration of calming and sleeping products in the Philippines, bright prospects are expected over the forecast period. With manufacturers focusing on the education of consumers, it is projected that calming and sleeping will be able to capture a wider consumer base especially among BPO employees and students. This category is predicted to witness a constant value CAGR of 8% while market will reach Ps68 million by the end of 2015.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional medications continued to gain greater popularity among Filipino consumers during 2010. Prompted by the increasing number of advertisements featuring the efficacy and safety of using herbal/traditional products compared to non-herbal variants, customers have become more interested in using the former to treat coughs and colds. Most herbal/traditional brands are made from lagundi (five-leaved chaste tree) with leaves that are traditionally boiled for the treatment of coughs and colds. Herbal/traditional brands are marketed to be as effective as lagundi without the inconvenience of picking the leaves, boiling, and letting them cool down before drinking. Since these brands are made from herbs, they are without side effects.

SWITCHES

COMPETITIVE LANDSCAPE

  • United Laboratories Inc sustained its leadership of cough, cold, and allergy (hay fever) remedies in 2010. The company’s total value sales of Ps3.4 billion accounted for 33% value share. The dominance of the company is due to the strong brand equity of its brands Neozep, Solmux, Decolgen, and Tuseran. The company employs a competitive pricing strategy and aggressive promotional policies in establishing its foothold in the category. Faced with the challenge of further expansion, the business organisation launched a campaign which highlighted consumers’ apathy for treating coughs and colds.

PROSPECTS

  • Cough, cold, and allergy (hay fever) remedies is poised to take advantage of the erratic weather conditions which are experienced in the Philippines due to global warming and climate change. Higher incidences of coughs and colds will be brought about by this development and could possibly drive volume sales. Through its promotions, United Laboratories has managed to make consumers more aware of the need to take strong measures to cure their colds rather than traditional methods of sleep and drinking water.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies manufacturers continued to bank on the power of tri-media advertising in order to push their products. Reckitt Benckiser (Philippines) Inc reportedly invested Ps20 million in advertisements for its newly-launched brand Gaviscon. On the other hand, United Laboratories Inc continued to maintain top-of-mind recall through the commercials for its brands Diatabs and Kremil-S. On the other hand, Dulcolax continuously expanded its shares through its aggressive tri-media advertising campaign.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Philippines) Inc sustained its dominance of digestive remedies accounting for 36% share of total sales during 2010. The company’s Ps597 million in value sales is largely accounted for by its two brands Imodium which leads diarrhoeal remedies and Bonamine which is the largest brand in motion sickness remedies, as well as the overall category. Johnson & Johnson is able to capture its target audience by strategically creating strong brand equity through advertisements.

PROSPECTS

  • The focus of digestive remedies will shift from addressing hygiene concerns which often cause diarrhoea into solving disorders which are brought about by evolving consumer lifestyles especially in urban areas. For instance, the rise in the number of people working in business process outsourcing has brought in more cases of stress and diet-related digestive problems. Inadequate sleep, fatigue, restlessness, inadequate intake of fruits and vegetables, and lack of fibre in the body are issues which are becoming more prominent and could drive sales of digestive remedies over the forecast period.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The incidence of ear wax accumulation and minor ear infections remained rare in the Philippines where ear cleaning is carried out on a daily basis through the use of cotton buds. Filipinos are known to strictly observe proper hygiene. At a very young age, children are often taught to clean their ears after bathing each morning. This strong concern in keeping the ears clean contributed to ear care’s sluggish performance in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • PL Asia Pacific’s Otosol sustained its dominance in ear care, taking advantage of its established brand equity in the country. The company’s value share reached 97% in 2010 amounting to Ps12 million, and its value sales growth marginally outpaced the category.

PROSPECTS

  • Ear care is predicted to remain as a very small category during the forecast period. It is less likely that the incidences of ear wax accumulation will increase in the medium-term noting that Filipinos are becoming more hygiene-conscious. During the forecast period, a constant value CAGR of -3% is predicted to total sales of Ps10.9 million in 2015.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The lack of advertising campaigns and other promotional strategies from manufacturers contributed to the slowdown in growth for eye care. Major players Johnson & Johnson (Philippines) Inc and GlaxoSmithKline Philippines Inc both reduced their spending on eye care promotional strategies and continued to focus on more vibrant categories within consumer healthcare.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Philippines) Inc continued to sustain its dominance in 2010. The long-standing presence of Visine and its relatively lower prices compared to major competitor Eye Mo enabled it to generate more demand from middle-income consumers. It should be noted that in 2010, Visine was priced 30% less per unit than Eye Mo. This huge price difference enabled it to win over other players especially as Filipino consumers continued to restrict their spending on eye care products. This also allowed Johnson & Johnson to outpace category growth and increase its share against GlaxoSmithKline Philippines Inc.

PROSPECTS

  • Eye care is predicted to continue to experience negative growth over the forecast period as companies are projected to remain inactive in pushing these products. During the forecast period, eye care will post a constant value CAGR of -2% to total Ps218 million by 2015.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2005-2010
  • Table 53 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 54 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 55 Eye Care Company Shares by Value 2006-2010
  • Table 56 Eye Care Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Manufacturers continued to capitalise on the perceived safety and efficacy of herbal/traditional products. Being made from herbs and traditional plants which are reputed to cure diseases, these products have established their efficacy. Aside from these factors, Filipino consumers are often attracted to using these products as they do not contain chemicals which could give adverse side effects to users. Thus, there is a general perception that consuming herbal/traditional products is safe and overdosing on most products would not be harmful.

COMPETITIVE LANDSCAPE

  • Universal Robina Corp continued to dominate herbal/traditional products with the leadership of its brand Maxx in medicated confectionery. During 2010, the company’s held 56% share of herbal/traditional products’ total revenue. The success of Maxx is attributed to its strong brand equity. It should be noted that Universal Robina Corp have long-established the brand through its aggressive advertising campaign. Being cheap and widely available through sari-sari stores, Maxx remains strong amid economic slowdown.

PROSPECTS

  • The forecast period will be a phase where natural remedies continue to take centre stage buoyed by consumers wanting to have safer yet effective alternatives. The technology in processing herbal/traditional brands will also improve, thereby increasing the number of new product developments launched in the Philippines.

CATEGORY DATA

  • Table 59 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 60 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 61 Herbal/Traditional Products Company Shares 2006-2010
  • Table 62 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 63 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 64 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The evolution of faster-paced consumer lifestyles among Filipinos led to higher demand for convenience products in medicated skin care. For instance, consumers preferred products which could be readily applied and are more efficient in lessening the frequency of application. For instance, brands such as Nizoral which stresses its efficiency through its once-a-day application has been very prominent during the year as customers would like remove the inconvenience of frequent applications. On the other hand, consumption of nappy (diaper) rash treatments was also boosted by the growing number of women joining the workforce who demand more convenient ways to treat this problem aside from the usual petroleum jelly.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Philippines) Inc remained the undisputed top player in medicated skin care holding 41% share of total retail sales in 2010. The player benefits from its portfolio of brands which are leaders in their respective segments. The company’s Trosyd and Nizoral Cream brands lead topical antifungals while Desitin and Retin-A are major players in nappy (diaper) rash treatments and acne treatments, respectively. Armed with strong financial muscle, Johnson & Johnson (Philippines) Inc is able to finance marketing campaigns which enable it to gain strong brand equity.

PROSPECTS

  • Medicated skin care will see more competition from beauty and personal care over the forecast period. As cosmetic manufacturers launch and strengthen their brands to become more efficient and value-adding, blurring between medicated skin care and beauty and personal care will become more of a likely trend. This development will be more prevalent in acne treatments where more beauty and personal skin care brands will be strengthening their portfolios to include more brands for oily skins and acne prone consumers. Other segments to be affected are hair loss treatments and medicated shampoos which will be negatively impacted by regular shampoos combating hair loss and dandruff. With beauty and personal care manufacturers investing in promotional campaigns, consumers’ perceptions about the difference between cosmetic and medicated skin care brands will continue to blur.

CATEGORY DATA

  • Table 65 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 66 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 67 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 70 Acne Treatments Brand Shares by Value 2007-2010
  • Table 71 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in the Philippines - Category Analysis

HEADLINES

TRENDS

  • The changing profile of consumers of sports nutrition led to a number of information awareness campaigns being carried out by sports groups in the Philippines. During 2010, the Sports Vision Institute of the Philippines in cooperation with the Department of Sports Science of the University of the Philippines College of Huma Kinetics held the First Philippine Sports Science Conference in the country which was participated by coaches, department officers, instructors, and students. In addition, a seminar entitled Recent Advances in Sports Nutrition while LAN Sports and Events Inc also embarked on a series of sports science seminars. These activities emphasised the importance of sports nutrition aside from training and introduced products which are suitable for athletes.

COMPETITIVE LANDSCAPE

  • GNC, which was acquired by Total Nutrition Corp in 2009 surpassed lovate Health Sciences Research Inc and became the largest player in Philippines sports nutrition. During 2010, the company was able to generate sales of Ps58 million accounting for 37% of total sales. The company’s launch of its own retailer brand GNC Pro Performance which is lower priced than brand Muscle Tech allowed it to capture new sports nutrition consumers.

PROSPECTS

  • Sports nutrition will remain vibrant, recording a constant value CAGR of 5% during the forecast period, to reach Ps198 million by 2015. The increasing awareness of the importance of sports nutrition among athletes, sports enthusiasts, and body builders is expected to stimulate demand during the forecast period. As more activities and seminars are conducted which stress the significance of complementing training with sports nutrition products, the consumer base will continue to widen giving more opportunities to players.

CATEGORY DATA

  • Summary 12 Sports Nutrition: Brand Ranking by Format 2010
  • Table 74 Sales of Sports Nutrition: Value 2005-2010
  • Table 75 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 76 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 77 Sports Nutrition Company Shares 2006-2010
  • Table 78 Sports Nutrition Brand Shares 2007-2010
  • Table 79 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 80 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Wary of the continued expansion of products with no curative effects, the Department of Health issued Administrative Order 2010-0008 which mandated manufacturers to clarify the “No Approved Therapeutic Claims” printed on vitamins and dietary supplements’ packaging and aired in advertisements. This will be done through a Tagalog translation which is expected to adequately inform consumers that vitamins and dietary supplements are not meant to be taken as medicine. Thus, packaging should be imprinted with this warning: Mahalaang Paalala: Ang (name of product) ay hindi gamot at hindi nararapat gamiting panggamot sa anumang sakit (Important Notice: This product is not medicine and is not to be used for treating diseases). This new regulation incited complaints from the Chamber of Herbal Industries in the Philippines but the Department of Health pushed the mandate through.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • United Laboratories Inc sustained its dominance of vitamins and dietary supplements with value share of 30% in 2010, to reach total sales of Ps4.6 billion. The company’s leadership in vitamins cemented its leadership. Its brands Ceelin, Enervon-C, Growee, Nutrilin, Ferlin, Nutroplex, and United American Tiki-tiki Plus Vitamins are all very prominent among Filipino consumers in child-specific vitamins and dietary supplements. Meanwhile, its brands Enervon-C, Myra E, and Revicon Forte are also making headways in single and multivitamins. The strength of these brands is attributed to the efficiency and strategic positioning which is backed by aggressive marketing campaigns. It should be noted that United Laboratories has yet to conquer the fast-growing dietary supplements segment.

PROSPECTS

  • Vitamins and dietary supplements is projected to grow further over the forecast period. The category is poised to reach Ps18 billion in constant terms by the end of 2015. Research and development is expected to play an important role in driving growth of vitamins and dietary supplements over the forecast period. Manufacturers are anticipated to focus on discovering new nutrients or improving their current offerings to suit the changing lifestyles of consumers. Thus, it is foreseen that new formulations, combinations and even new nutrient ingredientss will be visible between 2011 and 2015.

CATEGORY DATA

  • Summary 13 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 81 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 83 Dietary Supplements by Positioning 2005-2010
  • Table 84 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 85 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 86 Vitamins Brand Shares by Value 2007-2010
  • Table 87 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 88 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Traditionally, Filipinos’ motivation to lose weight is purely because of their desire for a better figure. However, there has been an increasing trend to lose weight as a way of obtaining a healthier body. With the realisation that obesity often exposes one to the risk of cardiovascular diseases; Filipinos are trying to lose weight to avoid these illnesses. It should be noted that in the Philippines, cardiovascular disease is among the top ten causes of mortality in 2009.

COMPETITIVE LANDSCAPE

  • Weight management, where 72% share of sales is accounted for by the highly fragmented weight loss supplements, is dominated by multinational Herbalife International Philippines Inc. During 2010, the company made Ps397 million in total value sales, which is 12% share of the category’s revenue. The strong position of the direct seller in the Philippines could be attributed to the efficacy of its products proven by the testimonial of users. Offering job opportunities to Filipinos, the brand performs better in times of economic slowdown where more people are looking to augment their incomes.

PROSPECTS

  • Over forecast period, weight management product is expected to reach at 2% CAGR or about Ps3.6 billion. As Filipinos in the middle and upper-income brackets become more health-conscious, consumption of weight management products could decelerate during the forecast period. Weight management is expected to see a constant value CAGR of 2% reaching Ps3.6 billion. It should be noted that the forecast period will see more middle-income patrons eating more vegetables and taking part in more physical activities in order to prevent obesity.

CATEGORY DATA

  • Table 90 Sales of Weight Management: Value 2005-2010
  • Table 91 Sales of Weight Management: % Value Growth 2005-2010
  • Table 92 Weight Management Company Shares 2006-2010
  • Table 93 Weight Management Brand Shares 2007-2010
  • Table 94 Forecast Sales of Weight Management: Value 2010-2015
  • Table 95 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in the Philippines - Category Analysis

HEADLINES

TRENDS

  • Through the aid of franchising, parapharmacies/drugstores and chemists/pharmacies continued to expand by double digits during 2010. Brands such as The Generics Pharmacy, Generica, Mercury Drug, and Rose combined the opening of more than 1,000 outlets, thereby increasing the channels where wound care brands are distributed. The increase in the number of outlets enabled wound care to tap more municipalities and broaden the geographical consumer base.

COMPETITIVE LANDSCAPE

  • Philusa Corp remained the largest player in wound care holding current retail value share of 62% which totals Ps305 million in 2010. The company’s competitive pricing strategy made it popular among the middle and lower-income buyers. This positioning and strategic alliance with large and small distributors made it readily available to customers. Its brand Mediplast is already a household name and has become synonymous with wound care.

PROSPECTS

  • Wound care is projected to post a constant value CAGR of -1% over the forecast period, to reach Ps469 million by the end of 2015. This sluggish performance of wound care will continue to be brought about by the general perception among Filipino customers that wounds should be exposed to air after treating with antiseptic in order for them heal immediately. Stimulating growth in the category would be tantamount to changing this perception. With no new entrant or new player investing in promotional campaigns, this perception will be upheld over the forecast period.

CATEGORY DATA

  • Table 96 Sales of Wound Care by Category: Value 2005-2010
  • Table 97 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 98 Wound Care Company Shares by Value 2006-2010
  • Table 99 Wound Care Brand Shares by Value 2007-2010
  • Table 100 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 101 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Isoflavones
            • Milk Thistle
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Glutathione
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report